The NIMA-related kinase family and cancer

Cancer is a disease where cells begin to divide uncontrollably and spread to other parts of the body. Mitotic kinases play a crucial role in the initiation and progression of all human malignancies, making them common therapeutic targets. However, a significant portion of the human kinome has yet to...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 15; p. 1556917
Main Authors Li, Haotian, Li, Junhan, Zhang, Yue, Cao, Ran, Guo, Congcong, Jiao, Mingwen
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.03.2025
Subjects
cancer
metastasis
mitosis
NEK family
Oncology
proliferation
therapeutic target
NEK family
cancer
therapeutic target
proliferation
mitosis
metastasis
Online AccessGet full text

Cover

More Information
Summary:Cancer is a disease where cells begin to divide uncontrollably and spread to other parts of the body. Mitotic kinases play a crucial role in the initiation and progression of all human malignancies, making them common therapeutic targets. However, a significant portion of the human kinome has yet to be functionally studied in cancer systems. The NIMA-related kinase family (NEKs), consisting of 11 members distributed across different cellular regions, are important protein kinases that regulate mitotic processes. Emerging research suggests that NEK family members have potential key roles in various malignancies. This review systematically summarizes the expression and regulatory mechanisms of NEK family members in different cancer systems, highlighting that targeting NEKs holds promise as a new therapeutic approach for inhibiting cancer growth and metastasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Udayan Bhattacharya, NewYork-Presbyterian, United States
Edited by: Prem S Subramaniam, Columbia University, United States
Reviewed by: Keith R. Laderoute, Laderoute Consulting, LLC, United States
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2025.1556917